LANCASTER, CA, January 18, 2012 – Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of simulation and modeling software for pharmaceutical discovery and development, today reported financial results for its first quarter of fiscal year 2012 ended November 30, 2011 (1QFY12). Results below are reported for continuing operations (without the discontinued operations of the Company’s former Words+ subsidiary), except as noted.

LANCASTER, Calif.--(BUSINESS WIRE)-- Simulations Plus, Inc. (Nasdaq:SLP), a leading provider of software and consulting services for pharmaceutical R&D and environmental toxicology, announced that it expects to file its quarterly report on Form 10-Q for the first quarter of its 2012 fiscal year, ended November 30, 2011, with the U.S. Securities and Exchange Commission today, Tuesday, January 17, 2012. Chairman and Chief Executive Officer Walt Woltosz will host a conference call to discuss the Company’s performance on Wednesday, January 18, at 1:15 p.m. PT / 4:15 p.m. ET.

LANCASTER, Calif.--(BUSINESS WIRE)-- Simulations Plus, Inc. (NASDAQ:SLP), a leading provider of software and consulting services for pharmaceutical R&D and environmental toxicology, today announced that Walt Woltosz, chairman and chief executive officer, will present at the Sidoti & Company Semi-Annual New York Micro-Cap Conference at 1:20 p.m. ET on Monday, January 9, 2012 in the Estate 3/Alvin room at the Grand Hyatt New York Hotel. Simulations Plus management will be available during the day for one-on-one meetings. To schedule a meeting, please contact your Sidoti representative.

LANCASTER, Calif.--(BUSINESS WIRE)-- Simulations Plus, Inc. (NASDAQ: SLP - News), a leading provider of consulting services and software for pharmaceutical discovery and development, today released preliminary revenues for its first fiscal quarter of fiscal year 2012, ended November 30, 2011 (1QFY12).

LANCASTER, Calif.--(BUSINESS WIRE)-- Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of software for pharmaceutical discovery and development, today reported its financial results for its 2011 fiscal year (FY11) and fourth quarter (4Q11) ended August 31, 2011.

LANCASTER, Calif.--(BUSINESS WIRE)-- Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of software and consulting services for pharmaceutical R&D and environmental toxicology, announced that it expects to file its annual report on Form 10-K, for the 2011 fiscal year ended August 31, 2011, with the U.S. Securities and Exchange Commission on Tuesday, November 29. Chairman and CEO Walt Woltosz will host a conference call to discuss the Company’s performance on Thursday afternoon, December 1, at 1:30 p.m. PST / 4:30 p.m. EST.

LANCASTER, Calif.--(BUSINESS WIRE)-- Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of consulting services and software for pharmaceutical discovery and development, today announced that it has signed a Stock Purchase Agreement with the Prentke Romich Company of Wooster, Ohio (PRC) to sell Simulations Plus™ wholly owned Words+ subsidiary to PRC for $2.1 million subject to ordinary adjustments for changes in net working capital. Closing is planned for November 30, 2011, to coincide with the end of the first fiscal quarter of Simulations Plus™ 2012 fiscal year

LANCASTER, Calif.--(BUSINESS WIRE)-- Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of consulting services and software for pharmaceutical discovery and development, today announced that its bid to purchase substantially all of the assets of Entelos, Inc., in an auction supervised by and in accordance with certain bidding procedures approved by the United States Bankruptcy Court for the District of Delaware and pursuant to the provisions of Section 363 of the U.S. Bankruptcy Code was not selected as the winning bid.

LANCASTER, Calif.--(BUSINESS WIRE)-- Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of consulting services and software for pharmaceutical discovery and development, today announced that it has submitted a bid to purchase substantially all of the assets of Entelos, Inc., in an auction supervised by and in accordance with certain bidding procedures approved by the United States Bankruptcy Court for the District of Delaware and pursuant to the provisions of Section 363 of the U.S. Bankruptcy Code. The auction will take place on September 21, 2011, and, if the Company’s bid is selected as the highest or best bid, then a sale hearing is expected to be held on September 23, 2011, to approve the sale of the assets.

LANCASTER, Calif.--(BUSINESS WIRE)-- Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of consulting services and software for pharmaceutical discovery and development, today announced that it has completed the molecule design phase of its malaria NCE (new chemical entity) project, and has issued requests for quotes to synthesize up to twelve compounds for testing.